Apyx Medical CorporationAPYXNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank7
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P7
Near historical low
vs 5Y Ago
-6.6x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-33.60%
20244.87%
20236.60%
20225.16%
202110.23%
20205.07%
201951.11%
20180.57%
2017-6.23%
201621.20%